Animal study · rats

BPC-157 limited isoprenaline-induced heart attack damage in rats

Checked against the paper Animal studyPublished by PepVault

The takeaway

This adds rat evidence that BPC-157 lessened drug-induced heart attack damage, but it has not been shown in people.

Kind
Animal study
Studied in
Rats
Published
2022
Journal
Biomedicines

What they tested

The team tested whether BPC-157 could counter heart attacks, repeat heart attacks and early damage to many organs brought on by the drug isoprenaline in rats.

How the study was done

An animal study in rats given isoprenaline at 75 or 150 mg/kg under the skin, either once or twice 24 hours apart, with heart results checked at the end of the next 24 hours. BPC-157 was given into the belly cavity at 10 ng/kg or 10 µg/kg, either 30 min before or 5 min after isoprenaline, and was compared with and combined with L-NAME, a blocker of nitric oxide production, and L-arginine.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking BPC-157? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In rats, BPC-157 lowered all the heart damage markers measured: CK, CK-MB, LDH and cTnT (cardiac troponin T). Treated rats showed no visible infarcted area, meaning no patch of dead heart muscle, and less damage under the microscope. Their ECG showed no ST-T changes linked to poor blood flow, and their echocardiography (heart ultrasound) showed preserved pumping function of the left ventricle. At 30 min after isoprenaline, BPC-157 given 5 min after the drug lessened early damage in the brain, heart, lungs, liver, kidneys and gut, along with clotting and abnormal blood pressures in several vessels, and it lowered measures of oxidative stress.

What it doesn’t show

This was done in rats with heart damage brought on by a drug, so it is not a human result. Effects were followed only over short periods, up to about 24 hours after the last isoprenaline dose.

The paper

Barisic et al. Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats. Biomedicines. 2022.

The compound

More studies on BPC-157

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking BPC-157? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo